Bruce N. Jacobs, Chief Financial Officer at Kymera Therapeutics, Inc. (KYMR), sold 12,789 shares at $30.33 ($389K) on 2025-03-03, disclosed to the SEC on 2025-03-03.
Seasonal sale ($389k) by Chief Financial Officer — this insider has traded KYMR in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.33 | 5,754 | $175K | 44.9% |
| 2 | $30.33 | 5,754 | $175K | 44.9% |
| 3 | $31.00 | 1,281 | $40K | 10.2% |
| Total | $30.40 avg | 12,789 | $389K | 100% |
| Filing → |
| KYMR | SELL | 2025-09-17 | $4.0M | — | Filing → |
| KYMR | SELL | 2024-03-04 | $318K | — | Filing → |
| KYMR | SELL | 2023-03-03 | $42K | — | Filing → |